Table 2.
PCR_RFLP primers, PCR conditions, and genotyping assays.
Position in gene | Allele | rs number | Genotyping assay | Primer name | Sequence (5′-3′) | Tm (°C) | Product size (bp) |
---|---|---|---|---|---|---|---|
−392 A>G | CYP3A4*1B | rs2740574 | MboII | 5′_F_m1 | GGA CAG CCA TAG AGA CAA GGG gA | 55 | 350 |
5′_R | GGC TAT GTG CAT GGA GCT TT | ||||||
−292 T>G | Novel | RsaI | 5′_F | CAG AAG GGA TGA CAT GCA GA | 55 | 575 | |
5′_R_m | CCT CCT TTG AGT TCA TAT TCT ATG AGG TAT CgT | ||||||
−215 T>A | rs144721069 | Hpy188III | 5′_F_m2 | TGT GTG TGT GAT TCT TTG CCA ACT TCt cAG G | 55 | 181 | |
5′_R | GGC TAT GTG CAT GGA GCT TT | ||||||
3847 A>G | Novel | NlaIII | E2_F_m | GCA GGA AAG GAC CTG ATG AAC AcA T | 55 | 323 | |
E2_R | AAG CTG CTC TTG GCA ATC AT | ||||||
5916 T>C | rs12721625 | BseNI | E3_F | TGA CGT CTC CAA ATA AGC TTC C | 60 | 301 | |
E3_R | AGG TTG ACA AGA GCT TCA TCC | ||||||
13969 G>A | Novel | ApoI | E5_F | TCT AGC ATA GGG CCC ATC AC | 60 | 352 | |
E5_R | CA GTG GAC TAC CCC TTG GAA | ||||||
14268 C>T | CYP3A4*23 | rs57409622 | AciI/Sequencing | E6_F_m/E6_F | GAT GTG TTG GTG AGA AAT CTG AGa C | 55 | 362/154 |
E6_R | GGA ATA ACC CAA CAG CAG GA | ||||||
14269 G>A | CYP3A4*15 | rs4986907 | AciI/Sequencing | E6_F_m/E6_F | GAT GTG TTG GTG AGA AAT CTG AGa C | 55 | 362/154 |
E6_R | GGA ATA ACC CAA CAG CAG GA | ||||||
15619 A>G | rs111768354 | Sequencing | |||||
15628 C>T | rs4987159 | Sequencing | |||||
15649 A>T | CYP3A4*24 | rs113667357 | Sequencing | ||||
15753 T>G | rs2687116 | Sequencing | |||||
15783 T>C | rs4987160 | Sequencing | |||||
15804 T>G | rs28988584 | Sequencing | |||||
15837 T>A | rs12721622 | Sequencing | |||||
17829 T>C | Novel | PsiI | E9_F | CAT CCT GCT TTC CAA GGA | 60 | 418 | |
E9_R | CCT GCA TGC CTC TAG AAA GTG | ||||||
20230 G>A | CYP3A4*1G | rs2242480 | RsaI | E10_F | TGA TGC CCT ACA TTG ATC TGA | 60 | 391 |
E10_R | CTG CCA GTA GCA ACC ATT TG | ||||||
20309 G>C | rs4986911 | HindIII | E10_F | TGA TGC CCT ACA TTG ATC TGA | 55 | 327 | |
E10_R_m | CAG TGA AAG AAT CAG TGA TTA aG | ||||||
20327 T>C | rs34738177 | MboII | E10_F | TGA TGC CCT ACA TTG ATC TGA | 60 | 391 | |
E10_R | CTG CCA GTA GCA ACC ATT TG | ||||||
21896 C>T | CYP3A4*12 | rs12721629 | PstI | E11_F | CCC GAA TGC TTC CCA CCT | 55 | 334 |
E11_R_m | CAT CTT TTT TGC AGA CCC TCT gcA | ||||||
23081 C>T | rs12721620 | HpyCH4IV | E12_F | GAC TGA AAG CTC CTA TAG TGT C | 60 | 598 | |
E12_R | CCA TGC TAA TCT ACA TGG GCT | ||||||
25721 A>G | rs3735451 | BsaJI | E13_F | GCC ATC ATA CCT AAT AAT CTG G | 60 Xhosa | 988 | |
E13_R | AT GTG CAG GAA AGC ATC TGA | 55 Others |
5′, 5′-upstream; E, exon; F, forward; R, reverse; m, mutagenic primer; lowercase and bold letters, mutagenic bases for the introduction of restriction enzyme recognition sites.